Anal Canal Mass
An anal canal mass is any abnormal growth, lump, or swelling arising in the short passage between the rectum and the anal opening. The range of possible causes is wide and skews heavily benign: haemorrhoids, skin tags, warts, abscesses, and fissure-related swellings account for the overwhelming majority. A smaller proportion represent anal cancer or other tumours requiring specific treatment. The practical difficulty is that these causes produce overlapping symptoms—bleeding, discomfort, itching, and a palpable lump—and cannot reliably be told apart by symptoms alone. Because the anal canal is directly accessible, examination and, where needed, biopsy resolve quickly what neither symptoms nor imaging can settle on their own.
What is it?
The anal canal is the final few centimetres of the digestive tract, running from the lower rectum to the anal opening. It is surrounded by two muscular rings—the internal sphincter, which works involuntarily, and the external sphincter, under conscious control—that together maintain continence.
A landmark within the canal called the dentate line separates two quite different types of tissue. Above it, the lining resembles that of the rest of the intestine and has no somatic pain sensation, which is why internal haemorrhoids typically bleed without hurting. Below it, the lining is more like skin and is richly supplied with pain-sensing nerves, which is why external haemorrhoids, fissures, and abscesses in this region can be intensely painful. This distinction also matters for cancer, since tumours above and below the line arise from different tissue types, spread to different lymph node groups, and are treated differently.
Anal canal mass is a descriptive finding rather than a diagnosis. The task is to determine what the lump is, and the reassuring background fact is that benign causes vastly outnumber malignant ones.
Haemorrhoids are the most common cause. They are enlarged, engorged vascular cushions that exist normally in the anal canal and contribute to continence, becoming symptomatic when they enlarge and prolapse. Internal haemorrhoids arise above the dentate line and characteristically produce painless bright red bleeding, sometimes with prolapse of tissue. External haemorrhoids arise below it and can be painful, particularly when a clot forms within one—a thrombosed external haemorrhoid, which presents as a sudden, exquisitely tender bluish lump.
Anal skin tags are soft, painless flaps of skin, often the residue of a previously thrombosed haemorrhoid or an old fissure. They cause hygiene difficulty and irritation but are otherwise harmless.
Anal fissures are tears in the lining, usually caused by passing a hard stool, producing sharp pain during and after defecation with bright red bleeding. A chronic fissure often develops a swelling at its outer edge called a sentinel tag or sentinel pile, which patients frequently notice as a lump and mistake for something else.
Perianal and anal abscesses arise from infection of the small glands that open into the anal canal. They present with increasing pain, a tender swelling, redness, and often fever. They require drainage rather than antibiotics alone, and a proportion subsequently develop an anal fistula—an abnormal track between the anal canal and the skin—which presents as recurrent discharge and a persistent lump or opening.
Anal warts, or condylomata acuminata, are caused by human papillomavirus and appear as small fleshy growths that may be single or extensive, inside the canal or on the surrounding skin. They are common, sexually transmissible, and important beyond their local nuisance, because the same virus family is responsible for most anal cancers.
Less common benign causes include hypertrophied anal papillae, which are small firm projections at the dentate line often mistaken for polyps; pilonidal disease, which occurs in the natal cleft rather than the anal canal itself but is frequently confused with it; hidradenitis suppurativa affecting the perianal skin; molluscum contagiosum; and perianal Crohn’s disease, which produces skin tags, fissures, abscesses, and fistulas and can be the first manifestation of Crohn’s disease before any intestinal symptoms appear.
Anal intraepithelial neoplasia represents precancerous change in the anal lining caused by persistent HPV infection. It is often invisible to the naked eye, may be detected on cytology or high-resolution anoscopy, and represents the stage at which intervention can prevent cancer developing.
Anal cancer is uncommon but is the diagnosis that shapes how any persistent or atypical lump is approached. Squamous cell carcinoma accounts for the large majority and is strongly associated with HPV, particularly types 16 and 18. It typically presents with bleeding, a lump, pain, and sometimes itching or a sensation of a mass—symptoms indistinguishable from haemorrhoids, which is precisely why it is so often diagnosed late. Adenocarcinoma of the anal canal is less common and may arise from anal glands or represent downward extension of a rectal cancer. Melanoma of the anal canal is rare, aggressive, and frequently amelanotic—lacking pigment—so it does not look like the pigmented lesion people expect. Other rare tumours include neuroendocrine tumours, gastrointestinal stromal tumours, lymphoma, and Paget disease of the perianal skin.
Risk factors for anal cancer are well characterised and are strongly weighted toward HPV and immune status. Persistent infection with high-risk HPV types is the dominant cause. HIV infection substantially increases risk, and the risk among men who have sex with men living with HIV is among the highest of any cancer risk group. Long-term immunosuppression after solid organ transplantation raises risk. A history of HPV-related disease elsewhere—cervical, vulvar, or vaginal precancer or cancer—is associated. Receptive anal intercourse, a higher number of sexual partners, and smoking all contribute. Chronic inflammation from longstanding perianal Crohn’s disease or fistulas is a less common but recognised route.
Symptoms overlap almost completely across causes, which is the central practical problem. Bleeding, pain, itching, discharge, and a palpable lump occur with haemorrhoids, fissures, warts, and cancer alike. Because haemorrhoids are so common, symptoms are frequently attributed to them without examination, and this assumption is the single most common reason anal cancer is diagnosed at a later stage than necessary. Delays of many months between first symptoms and diagnosis are well documented, and a substantial proportion of patients have been treated for haemorrhoids in the interim.
Features that should prompt closer evaluation include a lump that is hard, fixed, or progressively enlarging; ulceration; pain that is persistent and worsening rather than intermittent; bleeding that continues despite treatment for a presumed benign cause; change in bowel habit or narrowed stool; new faecal incontinence, which may indicate sphincter involvement; unintentional weight loss; and swollen lymph nodes in the groin, since the lower anal canal drains there.
Evaluation is direct and usually rapid.
Inspection of the perianal skin identifies external haemorrhoids, tags, warts, fissures, abscesses, and visible tumours. Digital rectal examination assesses the canal for masses, induration, tenderness, and sphincter tone. Anoscopy or proctoscopy visualises the canal directly and is essential, since internal lesions are not visible externally and are easily missed on digital examination alone.
Biopsy is performed on any lesion that is atypical, ulcerated, indurated, or not clearly benign. This is the step that most often makes the difference, and the threshold for it should be low.
Examination under anaesthesia is used when pain prevents adequate assessment. This situation is itself informative: pain severe enough to prevent examination warrants full evaluation rather than empirical treatment.
Flexible sigmoidoscopy or colonoscopy is indicated when there is bleeding or altered bowel habit, to assess the rectum and colon rather than assuming the anal finding explains everything.
MRI of the pelvis is the reference standard for staging anal cancer, defining the size and extent of the tumour, involvement of the sphincter complex and adjacent structures, and pelvic and inguinal lymph nodes. It is also excellent for mapping fistulas in perianal Crohn’s disease and in cryptoglandular fistula disease.
Endoanal ultrasound provides high-resolution assessment of the sphincters and of superficial tumour depth, and is useful in fistula assessment.
CT of the chest, abdomen, and pelvis assesses distant spread once cancer is confirmed, and PET-CT contributes to staging and to radiotherapy planning.
HIV testing is appropriate when anal cancer or high-grade precancerous change is identified, and HPV testing, anal cytology, and high-resolution anoscopy are used in screening and surveillance programmes for higher-risk groups.
Important to Know
The guiding principle for an anal canal mass is that it should be looked at. Most turn out to be benign and easily managed, but the small proportion that are not are curable when found early and considerably harder to treat when found late, and the difference between those outcomes often comes down to whether someone examined the area rather than treating symptoms empirically. Care is typically coordinated by primary care clinicians and colorectal surgeons, with oncology, infectious disease, and dermatology involved as needed.
Embarrassment is a genuine obstacle in this area and worth naming directly. Anal symptoms are among the most commonly delayed presentations in medicine, and patients frequently self-treat for months before seeking help. Clinicians are entirely accustomed to these examinations, and the assessment is brief. The practical consequence of delay is that a straightforward problem becomes a more difficult one.
Haemorrhoids are managed conservatively in the first instance with increased dietary fibre, adequate fluids, stool softeners where needed, avoidance of straining, and limiting time spent sitting on the toilet. Topical preparations provide symptomatic relief but do not treat the underlying problem. Persistent internal haemorrhoids respond well to office procedures, most commonly rubber band ligation. Surgical haemorrhoidectomy is effective but painful and is reserved for larger or refractory disease. A thrombosed external haemorrhoid, if seen within the first two to three days, can be relieved substantially by incision and clot removal; after that window it generally settles on its own with analgesia.
Anal fissures are treated by softening stool and relaxing the internal sphincter, since the pain causes spasm that reduces blood flow and prevents healing. Topical glyceryl trinitrate or calcium channel blocker preparations are first-line, with botulinum toxin injection and, for persistent fissures, lateral internal sphincterotomy as further options. Sphincterotomy is effective but carries a small risk of incontinence and is discussed carefully. A fissure in an atypical location—away from the midline—raises the possibility of Crohn’s disease, infection, or malignancy and warrants further assessment rather than standard treatment.
Perianal abscess requires prompt surgical drainage. Antibiotics alone are not adequate treatment for an established abscess and delay definitive care. A proportion of patients subsequently develop a fistula, which is assessed with MRI or endoanal ultrasound and managed according to its anatomy, with careful attention to preserving sphincter function.
Anal warts are treated with topical agents, cryotherapy, or excision depending on extent, with recurrence common. Their presence is an appropriate prompt to discuss HPV vaccination where relevant, to consider testing for other sexually transmitted infections including HIV, and to assess for internal involvement, since warts inside the canal are easily missed on external inspection alone.
Anal cancer treatment is notable for how much it differs from other digestive tract cancers. Squamous cell carcinoma of the anal canal is treated primarily with combined chemotherapy and radiotherapy rather than with surgery. This approach achieves high cure rates while preserving the sphincter and avoiding a permanent stoma in most patients, and it replaced radical surgery as the standard decades ago. Surgery, in the form of abdominoperineal resection, is reserved for disease that persists or recurs after chemoradiotherapy. An important practical point is that response can continue for months after treatment finishes, so persisting abnormality on early assessment does not necessarily indicate failure, and biopsy too early can be misleading. Immunotherapy has a role in advanced and recurrent disease.
Anal intraepithelial neoplasia is managed by surveillance or targeted treatment. Recent evidence has shown that treating high-grade precancerous lesions reduces progression to cancer in people living with HIV, which has strengthened the case for structured screening in higher-risk groups. Screening approaches vary by country and are evolving, generally combining anal cytology with high-resolution anoscopy for those with abnormal results.
Prevention is meaningful in this condition. HPV vaccination prevents infection with the types responsible for most anal cancers and is most effective when given before exposure, which is why routine adolescent vaccination programmes include boys as well as girls. Vaccination is also recommended for certain adults at higher risk. Smoking cessation reduces risk. For people living with HIV, effective antiretroviral therapy and engagement with surveillance programmes are important.
Perianal Crohn’s disease requires management of the underlying condition alongside local treatment, typically with biologic therapy combined with surgical drainage of sepsis, and is best managed jointly by gastroenterology and colorectal surgery.
Care is typically coordinated by primary care and colorectal surgery, with oncology, radiology, sexual health, and infectious disease involvement as needed. Examination, imaging, and clinical findings are interpreted alongside the patient’s symptoms, risk factors, immune status, and broader clinical context rather than in isolation.
Patient education plays an important role. Understanding that most anal lumps are benign, that symptoms cannot distinguish benign from serious causes, that assuming haemorrhoids without examination is the main route to delayed diagnosis, that anal cancer is usually treated without surgery and with sphincter preservation, and that HPV vaccination prevents most cases all contribute to appropriate care.
Red flag symptoms include a lump that is hard, fixed, ulcerated, or progressively enlarging; bleeding that persists despite treatment for a presumed benign cause; pain that is constant and worsening rather than intermittent or related to defecation; a fissure or ulcer away from the usual midline position; new faecal incontinence or difficulty controlling wind; change in bowel habit or narrowing of stool; unintentional weight loss; swollen lymph nodes in the groin; fever with severe perianal pain and swelling, suggesting abscess; and any anal symptoms in someone with HIV, on long-term immunosuppression, or with a history of HPV-related disease elsewhere. These warrant prompt medical evaluation and direct examination.